Diversity and Regulation of Astrocyte Neurotoxicity in Alzheimer's Disease

2021 ◽  
Vol 18 ◽  
Author(s):  
Sadayuki Hashioka ◽  
James G. McLarnon ◽  
Andis Klegeris

: Astrocytes contribute to brain development and homeostasis and support diverse functions of neurons. These cells also respond to the pathological processes in Alzheimer’s disease (AD). There is still considerable debate concerning the overall contribution of astrocytes to AD pathogenesis since both the protective and harmful effects of these cells on neuronal survival have been documented. This review focuses exclusively on the neurotoxic potential of astrocytes while acknowledging that these cells can contribute to neurodegeneration through other mechanisms, for example, by lowered neurotrophic support. We identify reactive oxygen and nitrogen species, tumor necrosis factor α (TNF-α), glutamate, and matrix metalloproteinase (MMP)-9 as molecules that can be directly toxic to neurons and are released by reactive astrocytes. There is also considerable evidence suggesting their involvement in AD pathogenesis. We further discuss the signaling molecules that trigger the neurotoxic response of astrocytes with a focus on human cells. We also highlight microglia, the immune cells of the brain, as critical regulators of astrocyte neurotoxicity. Nuclear imaging and magnetic resonance spectroscopy (MRS) could be used to confirm the contribution of astrocyte neurotoxicity to AD progression. The molecular mechanisms discussed in this review could be targeted in the development of novel therapies for AD.

2017 ◽  
Vol 9 ◽  
pp. 117957351770927 ◽  
Author(s):  
Rudy Chang ◽  
Kei-Lwun Yee ◽  
Rachita K Sumbria

Tumor necrosis factor α (TNF-α) plays a central role in the pathophysiology of Alzheimer’s disease (AD). Food and Drug Administration–approved biologic TNF-α inhibitors are thus a potential treatment for AD, but they do not cross the blood-brain barrier. In this short review, we discuss the involvement of TNF-α in AD, challenges associated with the development of existing biologic TNF-α inhibitors for AD, and potential therapeutic strategies for targeting TNF-α for AD therapy.


Author(s):  
Qin Zhang ◽  
KongBin Yang ◽  
ZhongLing Zhang ◽  
RuiHua Zhang

<b><i>Background:</i></b> Functional gene polymorphisms of proinflammatory cytokines such as tumor necrosis factor-α (<i>TNF-α</i>), interleukin-6 (<i>IL-6</i>), interleukin-8 (<i>IL-8</i>), and interleukin-18 (<i>IL-18</i>) may contribute to the onset and development of Alzheimer’s disease (AD), but the relationships between these polymorphisms and predisposition of AD remain controversial. <b><i>Objectives:</i></b> This meta-analysis was conducted to more robustly assess relationships between <i>TNF-α/IL-6/IL-8/IL-18</i> polymorphisms and predisposition of AD by pooling the findings of relevant studies. <b><i>Methods:</i></b> A comprehensive literature searching was performed in PubMed, Embase, Web of Science, Wanfang, and CNKI databases, and 63 studies were found to be eligible for quantitative analyses. <b><i>Results:</i></b> The pooled meta-analysis results showed that genotypic frequencies of <i>TNF-α</i> rs1800629, <i>IL-6</i> rs1800795, <i>IL-8</i> rs4073, and <i>IL-18</i> rs187238 polymorphisms among AD cases and controls of Asian ethnicity differed significantly. But, we did not observe such genotypic frequencies differences in Caucasians. <b><i>Conclusions:</i></b> This meta-analysis suggests that <i>TNF-α</i> rs1800629, <i>IL-6</i> rs1800795, <i>IL-8</i> rs4073, and <i>IL-18</i> rs187238 polymorphisms may affect predisposition of AD in Asians, but not in Caucasians.


2014 ◽  
Vol 62 ◽  
pp. 273-285 ◽  
Author(s):  
Kiran Bhaskar ◽  
Nicole Maphis ◽  
Guixiang Xu ◽  
Nicholas H. Varvel ◽  
Olga N. Kokiko-Cochran ◽  
...  

1998 ◽  
Vol 8 ◽  
pp. S276
Author(s):  
P. Bongioanni ◽  
B. Boccardi ◽  
D. Pellegrino ◽  
C. Baldini ◽  
L. Gabrielli ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document